Search: Aurora

Aurora Cannabis Reschedules Fourth Quarter and Full Fiscal Year 2021 Investor Conference Call and Related Year End Informational Filings to Monday, September 27, 2021

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has rescheduled its conference call to discuss the results for its fourth quarter and full fiscal year 2021 to Monday, September 27, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will…

Aurora Cannabis to Host Fourth Quarter and Full Fiscal Year 2021 Investor Conference Call and Related Year End Informational Filings

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and full fiscal year 2021 on Tuesday, September 21, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time. The Company will…

Jefferies upgrades Aurora Cannabis to hold as share prices ‘better reflect reality’

Jefferies on Friday upgraded shares of Aurora Cannabis Inc. to hold from underperform after the stock has fallen 10.5% so far this year. The U.S.-listed shares rose 0.9% in premarket trading. Analyst Owen Bennett said recent trading levels of the stock “better reflect reality” of operational weakness and the value of the company’s prospects to expand into the U.S. market…

MariMed, Hexo & Aurora Cannabis Among Top Cannabis Movers For September 1, 2021

GAINERS: cbdMd, Inc. (AMEX:YCBD) shares closed up 9.3% at $2.35 with an estimated market cap of $135.8M. Compass Diversified Hldgs (NYSE:CODI) shares closed up 8.85% at $31 with an estimated market cap of $2.0B. Arena Pharmaceuticals (NASDAQ:ARNA) shares closed up 7.29% at $56.78 with an estimated market cap of $3.5B. BioHarvest Sciences (OTC:CNVCF) shares closed up 4.19% at $0.32 with…

Aurora Cannabis Marks Successful Inaugural Fulfillment for French Pilot Program

Aurora Germany GmbH, a subsidiary of Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, and Ethypharm, have successfully delivered their initial shipment of cannabis to the French medical cannabis pilot program, set to begin serving patients in the coming weeks. Aurora and Ethypharm were selected by the National…